Royal Bank Of Canada Karyopharm Therapeutics Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,500 shares of KPTI stock, worth $4,030. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,500
Previous 7,950
18.24%
Holding current value
$4,030
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding KPTI
# of Institutions
98Shares Held
57.1MCall Options Held
604KPut Options Held
71.2K-
Vanguard Group Inc Valley Forge, PA7.65MShares$4.75 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$3.92 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$3.04 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.59 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$2.18 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $49.5M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...